Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_168304c1a86108c29fe8f3b84e3e279c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1c3ffd6cd7bf1c0d251e64ec8ce814b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2004-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79b7e0f4f42c7c0527e9c2170f79313d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43b853537cd21627fbcef21b7463800 |
publicationDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005226930-A1 |
titleOfInvention |
Pain relief composition, method to form same, and method to use same |
abstract |
An oral dosage form which includes a bi-layer tablet consisting of an Actives Granulation layer and an Osmagen Granulation layer is disclosed. An encapsulant is disposed over that bi-layer tablet. The encapsulated bi-layer tablet includes an orally therapeutically effective dose of oxycodone in combination with dextromethorphan, where the weight ratio of oxycodone to dextromethorphan is 1:5. The oral dosage form does not include an opioid antagonist. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309570-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005009916-A1 |
priorityDate |
2004-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |